Upgrades, downgrades, and outlook changes from major analysts.
Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.
1,356 total articles
Citizens analyst Matthew Carletti began coverage of Stewart Information Services (NYSE: STC) with a Market Outperform rating and an $80 price target. The firm cites attractive valuation versus peers, a solid balance-sheet profile and potential for margin expansion, while a recent public offering and executive appointment add momentum to the company…
Barclays downgraded Independent Bank Corp (INDB) from Equalweight to Underweight and set a $80.00 price target, citing persistent valuation pressure and specific credit risks tied to the bank’s office-lending portfolio. The move comes while Independent Bank reports strong quarterly results and a long dividend record, and after Raymond James raised …
JPMorgan upgraded Church & Dwight Co. Inc. (CHD) from Underweight to Neutral and increased its price target to $100.00 from $92.00, citing portfolio changes and recent quarterly results that point to stronger near-term growth while noting the company remains short of its long-term Evergreen model goals.
JPMorgan downgraded Best Buy from Overweight to Neutral and trimmed its price target to $76 from $99, citing near-term risks tied to computing demand, memory price dynamics and a potentially difficult fourth quarter of fiscal 2025. The bank highlighted that computing accounts for more than 35% of Best Buy's product mix and flagged softer trends in …
Guggenheim initiated coverage of Cullinan Oncology Inc. (NASDAQ:CGEM) with a Buy rating and a $30 price target, implying roughly 151% upside from the current share price of $11.96. The firm highlighted CLN-978, a CD19xCD3 bispecific, as the company’s key value driver and pointed to a slate of Phase 1 data readouts across autoimmune indications and …
HSBC downgraded Chevron from Buy to Hold while increasing its 12-month price target to $180 from $169. The new target sits marginally above Chevrons recent trading level, reflecting the banks view that the stocks year-to-date rally has tightened upside potential even as the firm maintains a favorable view of Chevrons cash flow trajectory and fi…
JPMorgan moved PTC Inc. (PTC) from Neutral to Underweight and trimmed its price target to $162 from $205, pointing to difficulties in shifting the company’s legacy Product Lifecycle Management (PLM) and Computer-Aided Design (CAD) products to a cloud-first, Software-as-a-Service model. The call comes as PTC shares trade near $156.13 after a more th…
JPMorgan has maintained its Underweight rating and SEK123.00 price target on Hennes & Mauritz AB after the retailer posted a stronger-than-expected fourth-quarter 2025 result. The bank attributes the outperformance mainly to lower operating expenses and a return to more typical writedown levels, but warns these factors may not persist. H&M’s board …
JPMorgan downgraded China Resources Power Holdings from Overweight to Neutral and reduced its target price to HK$17.00 from HK$21.50, citing concern that the removal of a tariff floor could pressure thermal tariffs beginning in 2027 and weigh on margins. The bank also highlighted uncertainty around government plans to adjust capacity charge mechani…
Jefferies launched coverage of Helus Pharma (NASDAQ: HELP) with a Buy rating and a $22.00 price target, implying roughly 232% upside from the current share price of $6.62. The firm identified three near-term catalysts in 2026 - a pivotal Phase III readout for oral d-psilocin HLP003, Phase II de-risking data for intramuscular d-DMT HLP004, and the a…
Unity Software shares fell roughly 20% after Google announced Project Genie, which offers prototype access to an interactive world model and creation engine for Google AI Ultra subscribers. William Blair reiterated an Outperform rating, arguing the market reaction exaggerates competitive risk given Unity’s platform depth, monetization model and AI …
Google opened Project Genie to Google AI Ultra subscribers in the United States, activating access to the Genie 3 generative platform and prompting a notable sell-off in a range of video game stocks. Genie 3, first previewed in August 2025, enables users to generate, explore and remix interactive worlds through text or image inputs. Market observer…
Raymond James raised its price target on Imperial Oil Ltd. to C$107.00 from C$106.00 but maintained an Underperform rating, citing what it views as rich valuation and limited near-term catalysts. Imperial Oil's recent quarterly results showed an EPS beat and a revenue shortfall, while the stock trades near its 52-week high and exhibits an overbough…
Baird increased its price target on Regeneron Pharmaceuticals to $742.00 from $630.00 following a fourth-quarter 2025 report that topped expectations for revenue and profit, while retaining a Neutral rating. The move comes amid stronger-than-expected performance from Eylea HD and continued momentum for Dupixent, and follows a wave of analyst update…
Evercore ISI removed Apple from its tactical outperform list after the company reported fiscal Q1 2026 results that beat expectations on both revenue and earnings. Apple posted $143.8 billion in revenue and $2.84 in EPS, driven by a 23% jump in iPhone sales and 13.9% growth in Services. Gross margins expanded to 48.2% as supply constraints limited …
Cantor Fitzgerald reduced its price target for Tenable to $30 from $42 but retained an Overweight rating, pointing to software multiple compression and limited visibility into federal spending as drivers of the revision. The firm still sees upside tied to Tenable One, cloud security demand, M&A and execution on AI and cloud initiatives, while other…
Raymond James increased its price target on QCR Holdings (NASDAQ:QCRH) to $103 from $88 and kept an Outperform rating after the bank reported strong fourth-quarter results. The brokerage pointed to robust swap fees, healthy balance sheet growth and a wider net interest margin as key contributors to recent earnings, while also trimming EPS forecasts…
BMO Capital has increased its 12-month price target for Brookfield Business Partners L.P. (NYSE:BBU) to $43.00 from $42.00 and kept an Outperform rating, citing solid portfolio company performance, continued favorable conditions for asset monetizations and expected higher new investment activity in 2026. The firm notes that units still trade at a n…
SoFi Technologies' stock fell about 4% to $23.08 after its latest quarterly report despite pre-market gains. Mizuho maintained an Outperform rating and a $38 price target, calling the quarter "outstanding" and arguing that investor worries about the loss of Chime as a client are exaggerated because guidance already reflected that change. The compan…
Truist Securities increased its price target on Robert Half (RHI) to $40 from $35 and maintained a Buy rating, while trimming EPS estimates for 2026 and 2027 due to higher expected SG&A costs. The staffing firm reported a modest fourth-quarter 2025 earnings and revenue beat, and its shares have fallen more than 55% over the past year, currently tra…
Stifel increased its 12-month price target for Plexus (PLXS) to $200 from $150 while keeping a Hold rating, a move that follows the company beating or meeting key fiscal first-quarter 2026 metrics and announcing program wins that bolster revenue guidance. Plexus shares are trading above the new target and above fair value measures, while analysts f…
Stifel reaffirmed its Buy rating on Thermo Fisher Scientific (TMO) and raised its price target to $700.00 after the company delivered better-than-expected results to close 2025. The firm points to Thermo Fisher’s sizable biopharma exposure and recent operating momentum as the rationale for anticipating mid-single-digit organic growth in 2026, while…
Stifel reaffirmed a Buy rating and a $188.00 price target on Neurocrine Biosciences (NASDAQ:NBIX) ahead of the company's fourth-quarter 2025 earnings due February 11. The firm made a small revision to Ingrezza sales to reflect one fewer selling week and highlighted both clinical progress and setbacks across the pipeline, while noting that consensus…
Stifel has reaffirmed a Buy rating on Starbucks (SBUX) with a $105 price target following the company’s Investor Day. The firm cited confidence in Starbucks’ plan to exceed 5% revenue growth and reach a 13.5% to 15.0% EBIT margin by fiscal 2028, supported by marketing initiatives and operational technology, even as the stock trades below that targe…
Stifel raised its price target on KLA Corporation to $1,700 from $1,600 and kept a Buy rating after the semiconductor equipment maker reported fiscal second-quarter results and provided third-quarter guidance that slightly exceeded both Stifel's and consensus expectations. KLA projects wafer fabrication equipment (WFE) spending to grow in the low-t…
